Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2024-11-08 00:00:00 ET · period of report 2024-11-06 · accession 0001104659-24-115867 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-08 | 2024-11-06+ | RYTM | Cramer Pamela J. | CHRO | S - Sale+OE | $62.50 | -9,375 | 13.5K | -41% | -$585.9K |
| DM | 2024-11-08 | 2024-11-06+ | RYTM | Cramer Pamela J. | CHRO | M - OptEx | $19.02 | +9,375 | 18.2K | +106% | +$178.3K |
| DM | 2024-11-08 | 2024-11-06+ | RYTM | Cramer Pamela J. | CHRO | M - OptEx | $0.00 | -9,375 | 18.8K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-06 | S | D | 4,687 | $60.00 | 13,500 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-06 | M | A | 4,687 | $19.02 | 18,187 | D | — | — | |
| 3 | Common | Common Stock | 2024-11-07 | S | D | 4,688 | $65.00 | 13,500 | D | — | — | |
| 4 | Common | Common Stock | 2024-11-07 | M | A | 4,688 | $19.02 | 18,188 | D | — | — | |
| 5 | Derivative | Stock Options (Right to buy) | 2024-11-07 | M | D | 4,688 | $0.00 | 14,062 | D | $19.02 · — to 2031-07-25 | 4,688 Common Stock | (F2) The stock options were granted on July 26, 2021. 25% of the shares subject to the option vested and became exercisable on July 26, 2022 and the remaining 75% of the shares subject to the option vest or have vested and become exercisable in 12 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer thereafter. |
| 6 | Derivative | Stock Options (Right to buy) | 2024-11-06 | M | D | 4,687 | $0.00 | 18,750 | D | $19.02 · — to 2031-07-25 | 4,687 Common Stock | (F2) The stock options were granted on July 26, 2021. 25% of the shares subject to the option vested and became exercisable on July 26, 2022 and the remaining 75% of the shares subject to the option vest or have vested and become exercisable in 12 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer thereafter. |